David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...

Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.

The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

EXCLUSIVE: The parents of two siblings with a life-limiting condition are waiting in agony to find out if health chiefs will ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The contentious move mandating that private healthcare facilities display medication prices is edging closer to reality, but not without further controversy.

President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...